Details of Disease
General Information of Disease (ID: DISG0DNJ)
Disease Name | Autoimmune lymphoproliferative syndrome type 2A | |||||
---|---|---|---|---|---|---|
Synonyms |
autoimmune lymphoproliferative syndrome, type IIA; autoimmune lymphoproliferative syndrome, type 2A; autoimmune lymphoproliferative syndrome, type 2; autoimmune lymphoproliferative syndrome caused by mutation in CASP10; autoimmune lymphoproliferative syndrome type IIA; autoimmune lymphoproliferative syndrome-CASP10 variant; ALPS-CASP10; autoimmune lymphoproliferative syndrome, type II; ALPS2A; CASP10 autoimmune lymphoproliferative syndrome; type 2 autoimmune lymphoproliferative syndrome; type 2 ALPS
|
|||||
Definition |
A rare, primary immunodeficiency with an autosomal dominant pattern of inheritance but incomplete penetrance. It is caused by a mutation in the CASP10 (caspase-10) gene that leads to defective Fas-induced apoptosis. Disruption of Fas-induced apoptosis impairs lymphocyte homeostasis and immune tolerance. Characteristic laboratory findings include an increase in circulating, double-negative (CD4-/CD8-) T cells in the setting of immune-mediated anemia, thrombocytopenia and neutropenia. Clinical signs present in childhood include fatigue, pallor, bruising, hepatosplenomegaly and chronic, non-malignant, non-infectious lymphadenopathy. The clinical course is influenced by a strong association with other autoimmune disorders and an increased risk for developing Hodgkin and non-Hodgkin lymphoma.
|
|||||
Disease Hierarchy | ||||||
Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This Disease Is Related to 2 DTT Molecule(s)
|
||||||||||||||||||||||||||||||
This Disease Is Related to 1 DOT Molecule(s)
|
||||||||||||||||||||||||||||||
References